← All comparisons
Head-to-head · FAERS comparison

Methotrexate vs Cyclophosphamide For: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

MethotrexateCyclophosphamide For
Drug class––
Brand names–Cyclophosphamide
FAERS reports483,097175,993
Serious73%96%
Death outcome37,64035,641
Boxed warningYes WARNING: EMBRYO-FETAL TOXICITY, HYPERSENSITIVITY REACTIONS, BENZYL ALCOHOL TOXICITY, and OTHER SERIOUS ADVERSE REACTIONS • Methotrexate Injection can cause embrNo

Signals both drugs share

No strong shared signal after removing coding and lab terms.

Labeled signals distinctive to Methotrexate

Labeled signals distinctive to Cyclophosphamide For

Common questions

Which has more reported side effects, Methotrexate or Cyclophosphamide For?

Methotrexate has 483,097 FAERS reports and Cyclophosphamide For 175,993. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (73% vs 96%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Methotrexate and Cyclophosphamide For share?

They share no strong flagged signal after artifacts and lab terms are removed.

Is Methotrexate or Cyclophosphamide For safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.